Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

PHASE1CompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

May 31, 2007

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

7-valent pneumococcal conjugate vaccine

BIOLOGICAL

Diptheria and tetanus toxoids and accelular pertussis vaccine (DTaP)

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488826 - Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants | Biotech Hunter | Biotech Hunter